Blog
About

  • Record: found
  • Abstract: found
  • Article: not found

p53 mutations in matched primary and metastatic human tumors.

Molecular carcinogenesis

Adenocarcinoma, genetics, Adult, Aged, Base Sequence, Breast Neoplasms, Carcinoma, Ductal, Breast, DNA Primers, chemistry, Female, Gastrointestinal Neoplasms, Genes, p53, Humans, Male, Middle Aged, Molecular Sequence Data, Mutation, Neoplasm Metastasis, Sequence Deletion, Tumor Suppressor Protein p53

Read this article at

ScienceOpenPubMed
Bookmark
      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

      Abstract

      Mutations in the p53 tumor suppressor gene have been found to be the most frequent genetic alterations in human malignancies. To further examine the idea that neoplastic progression is associated with mutations in the p53 gene, we analyzed matched primary and metastatic tumor samples. The samples included 15 pairs of breast cancer and metastases to lymph nodes, four pairs of gastrointestinal adenocarcinomas and metastases to liver, one colon adenocarcinoma and metastasis to a lymph node, and one lung carcinoma and metastasis in the pleura. Genomic DNA or cDNA from each tumor sample was amplified by the polymerase chain reaction and labeled by using one biotinylated primer. The DNA strands were separated with magnetic streptavidin beads and sequenced directly. p53 mutations were detected in 11 of 21 patients (52%) in either primary tumors, metastases, or both. In six of these patients the primary tumor and matched metastasis shared the same single mutation. In the other patients an additional mutation in the primary tumor only or a mutation in the metastasis only was observed. Our data suggest that tumor development and progression toward metastasis involves structural alterations in the p53 gene that occur early in carcinogenesis. In some cases, genetic changes in metastatic spreading may also include the appearance of a mutation in a metastasis derived from a primary tumor expressing wild-type p53, a selection of metastatic cells with a single mutation from a primary tumor expressing two different mutations, or loss of heterozygosity.

      Related collections

      Author and article information

      Journal
      7619219

      Comments

      Comment on this article